ilmscore | Prediction Details
By Stock Market Live | July 30, 2024 | Pending
Interpreted Prediction
Pfizer (PFE) believes the annual peak sales potential for its RSV vaccine (Abrysvo) is now 'more promising' than the previously stated $2 billion due to strong emphasis from the medical community.

Prediction Details

Ticker

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.